Dimercaprol
Severe
Database
Clinical effect not specified
Source: DDInter
Drug reference
sodium ferric gluconate complex
Parenteral Iron Supplement · Antianemic
Parenteral Iron SupplementAntianemic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
1 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactions
- DimercaprolSevereDatabaseDDInter
Mechanism
Not yet extracted
Indications
iron deficiency in patients with chronic kidney disease undergoing hemodialysis in conjunction with supplemental EPO therapy
Dosing
- Adult
- Multiple doses of 125–250 mg. A 125-mg dose is administered over 1 hour.
Contraindications
- pregnancy (due to benzyl alcohol preservative)
Side effects
Serious
- anaphylactic reactions (lower risk than iron dextran)
Drug interactions
11 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Related guidelines
Chronic kidney disease — assessment and management
KDIGO · Nephrology · 2024
Iron deficiency anaemia in pregnancy
ICMR · Obstetrics & Gynaecology · 2022
Iron deficiency anaemia in adults
ICMR · Hematology · 2023
Chronic kidney disease — assessment and management
NICE · Nephrology · 2021
Diabetes management in chronic kidney disease
KDIGO · Nephrology · 2022
Other Parenteral Iron Supplement drugs
Ask House about sodium ferric gluconate complex
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team